Materials and Methods
Mice. Mice were bred and maintained in the Mouse Immunogeneties Colony, Mayo Clinic, with the exception of DBA/IJ mice, which were obtained from The Jackson Laboratory, Bar Harbor, Maine.
Collagen. Native type II collagen was purified from lathyritic chick preparations by the method of Cremer et al. (13) .
Induction of Arthritis. Native type II collagen was solubilized in 0.1 M acetic acid at 1 mg/ ml, and emulsified in complete Freund's adjuvant (CFA). Mice were primed with 100/zg of type II collagen in CFA injected intradermally at four to six sites on the back. Control mice were primed with acetic acid emulsified in CFA. Mice were challenged after 21 d with 100 btg of type II collagen in 100 #1 acetic acid, injected intraperitoneally. Control mice received 100 #1 of 0.1 M acetic acid alone, intraperitoneally.
Assessment of Arthritis
MEASUREMENT OF JOINT THICKNESS. Mouse joints were measured using a constant tension caliper (Schelhaster, Syitem, Krfplin, Germany). All mice were measured before the start of the experiment to obtain base-line readings at three joints on the hind limb (paw thickness, ankle width, and knee width) and two joints on the fore limb (paw thickness and elbow width).
All mice of a strain with any visual appearance of arthritis were measured daily to observe the progress of joint swelling during the course of the disease, and to measure the variation in measurement of normal joints.
CLINICAL EVALUATION. All mice were examined daily for the initial visual appearance of arthritis: redness and swelling of a fore or hind paw. Dates of onset of the disease after immunization were recorded for individual mice.
An arthritic index of the disease was developed, based upon the visual appearance of a limb and the caliper measurements. Limbs were graded 0-3, representing increased joint swelling, erythema, and visible joint distortion. Changes in the number of affected limbs and the arthritis index for each limb were recorded on a daily basis.
HISTOLOGICAL EVALUATION. Mice were killed at various intervals during the experiment. Histological sections were prepared by the Pathology Department, Mayo Clinic. Limbs were dissected out for histology, and the clinical joint assessment was coded for blind observation. Joints were decalcified in Surgipath Decal (Medical Industries, Inc., Northbrook, Ill.) for 3-4 d and embedded in paraffin blocks. Sections of 6-pm thickness were cut along a longitudinal axis at a number of varying depths for each joint, mounted, and stained with hematoxylin and eosin before grading. The histological grading system was based upon (a) inflammation (b) erosion and pannus formation, and (c) ankylosis.
Antibody Quantitation. Mice were bled for sera on at least three occasions during the experiments: (a) day 7, primary response; (b) day 28, secondary response; and (c) bleed out.
Sera were tested for antibodies to type II collagen using a solid-phase radioimmunoassay, developed from the method of Clague et al. (14) .
Polystyrene tubes (LP3 Luckhams, Sussex, England) were coated with type II collagen by the addition of 3/,tg of collagen solubilized in 20 ~1 of 0.1 M acetic acid, followed by 500 #1 of phosphate-buffered saline (PBS). After overnight incubation at 4°C and washing three times with 1 ml PBS, the remaining protein binding sites were blocked by the addition of 500 pl of 0.1% bovine serum albumin (BSA) in PBS for 4 h at room temperature. The tubes were washed three times with 1 ml PBS before the addition of 10/~1 of mouse test sera and 500 ~1 of 0.1% BSA/PBS. The preparation was incubated overnight at 4°C, then washed three times with 1 ml PBS. Bound IgG was measured by the addition of iodinated (1~I) Staphylococcus protein A, 0.025 pg in 500/xl BSA/PBS for 45 rain at 4°C. The tubes were washed three times with 1 ml PBS and bound 12hi-Staphylococcus protein A measured in a gamma counter (Beckman Instruments, Inc., Fullerton, Calif.).
The quantity of IgG anti-type II collagen antibody was expressed as micrograms per milliliter by comparison against a purified guinea pig anticollagen IgG control.
Results
Characteristics of Type H Collagen-induced Arthritis. The intradermal injection of 100 pg of type II collagen in CFA, followed by a further 100 #g injected intraperitoneally after 21 d, induced an arthritis in a variable percentage of mice of susceptible strains.
The initial signs of collagen arthritis were swelling and erythema in one or more paws. The disease would progress at a variable rate, and other limbs could become involved at later intervals. Increases in paw thickness (arthritis/preonset) were recorded from 1.16-2.25, with a mean of 1.78 at peak disease. The variation in clinical limb score from 0-3 is exemplified by Fig. 1 A and B. T h e n u m b e r of limbs involved and the stage of the disease allowed a clinical score of 0-12.
The date of onset of collagen arthritis was extremely variable: from 19 d after the initial injection (preboost) to 112 d, with a mean of 46.8 d. T h e date of peak disease was also variable, with a mean of 10.8 d after onset.
No involvement of vertebral joints or other extraarticular manifestations was observed in type II collagen arthritis in mice. No control mice receiving adjuvant and acetic acid alone were observed to suffer any form of arthritis.
Histological Appearance of Collagen Arthritis.
Results of the histological section are shown in Figs. 2 and 3. Fig. 2 shows a section through a mouse foot. T h e section reveals the tarsal area with the articular surface of the tarsal bones covered with hyaline cartilage that is of uniform thickness and has a smooth surface. The synovial lining is barely perceptible and is one to two cell layers thick. Soft tissues surrounding the joint are normal. Fig. 3 shows the grading system used in this study. In some sections the only abnormality seen was mononuclear cell proliferation in the superficial layers of the synovium-stage I (Fig. 3 A) . This could be seen to progress to pannus formation with damage to the superficial layers of the cartilage--stage 2 ( Fig. 3 B) . In each animal the range of involvement varied from normal joints to stage I-IV destruction. There was good correlation between the clinical score and the histological score (Table I ) except for B10.S animals that clinically were normal but revealed some mononuclear cell hyperreactivity in the synovial lining. There was no pannus identified and no cartilage or bone destruction noted.
Strain Differences in Susceptibility to Type H Collagen Arthritis. Two categories of mice were studied to investigate genetic differences in susceptibility to type II collagen arthritis (Table II) : first, inbred mice of known H-2 type with varying background genes, and second, inbred mice of varying H-2 haplotypes congeneic to the B10 background.
Only mice bearing the H-2 q haplotype (B10.Q, B10.G, and DBA/IJ) were suseep- (Table III) (Table IV) . The susceptibility to collagen arthritis was dominant in the F1 animals, with a similar incidence of arthritis as that of the parental (B 10.Q) strain observed in the (B 10.Q × B 10.M)Fz, but a low incidence of the disease in the (B10.Q × B10.A[4R])Fx (Table IV) . Further crosses are under investigation to study the incidence of arthritis in F1, F2, and backcross mice.
Strain Differences in the Incidence and Appearance of Type H Collagen Arthritis. The incidence, onset, and gradation of collagen arthritis for each susceptible strain are summarized in Table V . The incidence of arthritis in B 10.Q mice was 75%. No significant differences were seen in the time of disease onset between strains. However, comparison of the maximum clinical score observed between strains revealed a significant variation in disease severity between B 10.Q and B 10.G, both strains of which carry the H-2 q haplotype. Table V shows B10.G to have a lower disease incidence, fewer involved limbs, and a lower clinical score than B10.Q. Independent t tests showed significant differences in the comparison of arthritis mice of the two strains (P < 0.05), and when the strains were compared overall (which tests for the low incidence in B10.G), the difference was highly significant (P < 0.01). A similar difference was seen in the comparison of B10.G with B10.DA; however, no other differences between strains were observed. (Table V) are not significantly different from the mean antibody levels in comparable strains (Fig. 4) .
The Genetic Control of

Discussion
These data indicate that the intradermal injection of native chick type II collagen in CFA may induce arthritis in ~50% of mice of susceptible strains.
The arthritis was characterized by initial redness and swelling of one or more limbs, which resulted in increases of paw thickness of 30-120%. Later clinical characteristics of the disease included gross joint deformation and total loss of joint mobility. The time-course of the disease was extremely variable, with disease onset varying from 19-112 d after the primary injection. Also, the involvement of other limbs after the onset was unpredictable. Mice with single limb involvement appeared most likely to experience disease recession; however, no spontaneous exacerbations were observed in any animal after recession. The examination of sections of affected joints revealed a good correlation between the clinical score and the histological score in type II collagen arthritis. No clinical or histological evidence of arthritis was seen in control animals receiving CFA and acetic acid alone.
The clinical and histological appearance of collagen arthritis in the mouse is essentially similar to that described in the rat (1), however, the median onset date was later in mice, and additional limbs showed involvement at periods >48 h. Peak severity of the disease was also attained after a longer period in the mouse.
These results are in agreement with the findings of Courtenay et al. (12), who also demonstrated a further increase in the disease time-course by using incomplete adjuvant.
Because the induction of arthritis is dependent upon the intradermal injection of type II collagen in adjuvant, it is conceivable that the delayed development of the disease in mice may be related to the lack of arthritogenic activity of adjuvant in mice. Also, because CFA is nonarthritogenic in mice, it is apparent that the type II collagen presented in this manner is responsible for the disease.
The initial experiments of this study indicated that only mice bearing the H-2 q haplotype were susceptible to type II collagen arthritis. The influence of non-MHC genes upon susceptibility to type II collagen arthritis is unclear because DBA/IJ mice showed a similar incidence and course of the disease as did B10.Q. mice, whereas B10.G mice, with similar background and MHC genes as Bl0.Qmice, showed a lower incidence and less severe course of collagen arthritis. This may indicate that the susceptibility gene of collagen arthritis may be linked to the MHC genes responsible for the expression of H-2 q antigens, and the different origin of MHC regions in B 10.Q. and B 10.G may have influenced the action of the disease susceptibility gene to some extent. Investigation of (B10.G × B10.Q)F1 animals is at present underway to study this phenomena. The use of recombinant congenic mouse strains further mapped the susceptibility to be controlled within the I q region. This genetic specificity of collagen arthritis was not observed by Courtenay et al. (12) , however, this may indicate that the response to bovine collagen may differ in genetic control to the response to chick collagen. The humoral (15, 16) and cellular (17) immune response to bovine collagens is under the control of H-2-1inked Ir genes. We can postulate that Ia antigens on macrophages of I q strains can effectively present type II chick collagen to trigger antiself response. On the other hand, Ia d'b'~ may be presenting the chick type II collagen in a manner in which only heterologous antibodies are generated.
It has also been proposed that the native type II collagen molecule contains at least two antigenic determinants (18) . It is conceivable that immunization with extracted type II collagen could elicit an immune response against collagen determinants that are hidden within the cartilage of the joint. Such an immune response should be detectable by the in vitro assay against the immunizing agent, extracted collagen, but the response should not be pathogenic due to the inaccessibility of the determinant in vivo. However, should the response be directed against collagen determinants that are expressed on joint cartilage, it is possible that autoimmune damage could result. Thus, the immune response seen in I q haplotype mice may indicate a specific response against type II collagen antigenic determinants expressed within the joint. Alternatively, it is conceivable that the immune response of I q haplotype mice to chick type II collagen cross-reacts with autologous mouse collagen and results in an autoimmune disease, whereas the response in other strains is confined to determinants specific for chick type II collagen. Thirdly, it may be that the immune response to collagen is against a common antigen determinant in all mouse strains, whereas the response of I q haplotype mice is higher than other strains. A more aggressive response by I q haplotype mice might result in damage to the joint cartilage and lead to inflammation and arthritis. However, high antibody responses were observed in three strains not expressing I q. The level of antibody in B 10.D2 (H-2 a) was equivalent or higher than that observed in all the arthritis-susceptible (I q) strains. Thus, antibody titer as measured by RIA is not an accurate prediction for the onset of arthritis. Similarly, the antibody responses within a susceptible strain were not indicative of the development of the disease. Arthritic mice overall showed a tendency to produce higher anticollagen antibody titers than nonarthritic mice, but arthritis was observed in animals with low antibody titers, particularly in B10.G mice. Studies to determine the role of the cellular response to type II collagen in arthritis and its relationship to disease susceptibility are being conducted at present.
The relationship of type II collagen arthritis in mice to RA would be worth exploring. The histological data in particular indicate that the features observed within the joint correspond to the histological appearance of RA. It is particularly relevant to examine any relationship that the H-2 q antigens of mice may have to the expression of HLA-DRw4 in man, either in structural similarity or linkage to the control of immune responses. It is known that 70% of RA patients have circulating antibodies to type II collagen (5) , and recent work by Solinger and colleagues (19) indicates that individuals with HLA-DRw4 have an abnormal leukocyte response to collagen.
Type II collagen arthritis in mice may prove a valuable model for the study of histocompatibility-linked arthritis in man. Summary A model of arthritis was established by the injection of type II collagen into mice. Only mice bearing the H-2 q haplotype were susceptible to the disease. Susceptibility was further mapped by the use of recombinant strains to the I q locus. Type II collagen arthritis was observed in the (resistant × susceptible)Fx cross.
Mice strains were designated high, intermediate, or low responders with respect to the anti-type II antibody levels measured by radioimmunoassay. Arthritis-susceptible strains were all classified as high antibody responders.
The clinical and histological appearance of type II collagen arthritis in the mouse indicates that it may be a good animal model for the investigation of various immunogenetic traits in rheumatoid arthritis.
